In rabbits nearly all B lymphocytes express the glycoprotein CD5, in contrast to mice and humans, where only a small proportion of B cells express this molecule (Raman, C., and K.L. Knight. 1992.J. Immunol. 149:3858-3864). CD5 + B cells appear to develop early in ontogeny and be maintained throughout life by self-renewal. The function of CD5 on B cells is still unknown. We showed earlier that "positive" selection occurs during B lymphocyte development in the rabbit appendix. This selection favors B cells expressing surface immunoglobulins with VHa2 structures in the first and third framework regions (Pospisil, P,.., G.O. Young-Cooper, and tL.G. Mage. 1995. Proc. Natl. Acad. Sci. USA. 92:6961-6965). Here we report that F(ab')2 fragments, especially those bearing VHa2 framework region determinants, specifically interact with the B cell-surface glycoprotein CD5. This interaction can be inhibited by anti-CD5 antibodies. Furthermore, immobilized F(ab')2 fragments selectively bind CD5 molecules in appendix cell lysates. Interactions of V H framework region structures with CD5 may affect maintenance and selective expansion of particular B cells and thus contribute to autostimulatory growth of autoimmune or transformed cells.
D
uring B cell development a rigorous selection process acts on newly formed B cells. Those beating self-reactive Ig molecules can be eliminated (1, 2) , undergo receptor editing (3, 4) or develop clonal anergy (5) (6) (7) . In addition, B cells appear to receive positive signals for survival (8) (9) (10) . Superantigens or self-antigens interacting with evolutionarily conserved "family-specific" sequences in the first and third framework regions (FR) I and FR3) of the VH may have the potential to significantly skew the composition of the B cell repertoire (10) (11) (12) .
In normal rabbits of the VHa2 haplotype, the majority of peripheral B cells that have undergone a productive VH-DH-JH gene rearrangement use the VHa2 allotype-encoding VH1 gene (13--15) . The VHa2 specificities were found to correlate with consistent differences in the amino acids at certain positions in FI<I and FR3 (13, 16) . Alicia (all) VHmutants (17) have a small deletion encompassing the VH1 gene at the 3' end of the VH cluster (13, 15) thus most of the B cells in young all/all rabbits are VHa2 negative. We showed earlier that B cells producing surface immunoglobulin with Ft<I and FR3 VHa2 allotypic structures are pref1Abbreviations used in this paper: all, Alicia; BCP,., B cell receptor; FP,., framework region. la,. PospisiI is on leave from the Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague. erentially expanded and positively selected during their development in the appendix (18) . The antigen or Iigand(s) responsible for this selection, however, were not determined. In this study we provide evidence for CD5-VH framework region interaction. The interaction between CD5 and B cell surface immunoglobulin may affect maintenance and selective expansion of particular B cells and may be a promoting factor in the evolution of autoimmune or transformed cells.
Materials and Methods
Animals, Reagents, and Antibodies. Rabbits of the VHa2 (F-I) or VH mutant all (F-I) haplotype were bred and raised in our own National Institute of Allergy and Infections Diseases allotypedefined pedigreed colonies. The antibodies used in this study were mouse mAbs to rabbit CD5, RCD5 (19) and human CD5, T1 or T1-RD1 (Coulter Corp., Hialeah, FL), biotin-conjugated mouse anti-rabbit CD4 and mouse anti-rabbit CD8 (Spring Valley Laboratories Inc., Woodbine, MD), biotin conjugated polydonal anti-rabbit IgM (Southern Biotechnology Associates, Birnfingham, AL), biotin-conjugated goat anti-mouse IgG and FITClabeled normal goat IgG (Jackson ImmunoResearch Laboratories, Inc., West Chester, PA), avidin conjugated to biotinylated glucose oxidase (ABC-GO; Vector Laboratories, Inc., Burlingame, CA), nitro blue tetrazolium in conjugation with 5-bromo-4-chloro-3-indotyl phosphate (Sigma Chemical Co., St. Louis, MO), Dynabeads M-450 and M-280 streptavidin (Dynal Inc., Great Neck, NY). . Biotinylated F(ab')2 fragments stain dark zone cells of appendix germinal center and the staining is inhibited by anti-Cl)5 antibody. Appendix tissue sections were stained with (a) VHa2 + F(ab')2-biotin; (b) anti-CD5 antibody RCD5; (c) anti-CD5 antibody RCI)5 followed by VHa2 ~ F(ab')~-biotin; (a t) VH-biotin; (e) purified V. followed by anti-CD5 (T1) antibody.
Tissue Staining and lmmutwhistochemistry. The preparation and purification of F(ab')2 fragments was described previously (20) . Briefly, a globulin fraction of rabbit serum was first prepared by precipitation with ammonium sulfate (50% saturation). The precipitated proteins were dialyzed against acetate buffer, pH 4.5, and digested with pepsin (2 mg/100 mg protein) for 18 h at 37~ Digests were dialyzed against PBS. The residual undigested IgG was removed with protein A-Sepharose. The isolation of VH fragments was described previously (21) . The purified F(ab')2 and V H were biotinylated with a biotinylation kit using NHS-LC-biotin (Pierce Chemical Co., Rockford, IL). Semithin 7-1.am serial sections of mutant VHa2-rabbit appendix collected at 6 wk of age were cut and incubated as described (18) . In Fig. 1 , tissue sections were stained with the primary reagent, mouse anti-rabbit CD5 mAb, R C I ) 5 (b and c) or isotype-matched control, normal mouse IgG2a (a) tbllowed by VHa2 F(ab')2-biotin (a and c) or biotin-conjugated goat anti-mouse IgG (Jackson hnmunoResearch Laboratories) (b). In (d) the tissue section was stained with VH-biotin and in (e) with VH followed by anti-CD5 (T1) antibody and then with biotin-conjugated goat anti-mouse IgG. The sections were then incubated with A B C -G O and labeled cells visualized by nitro blue tetrazolium in conjunction with BCIP.
CellAttachment Assay, Iinnaulon 4 flat-bottom plates (Dynatech Laboratories, Inc., Alexandria, VA) were coated with VHa2 + or mutant VHa2-F(ab')2 fragments diluted in (IA M N a H C O 3 and incubated at 4~ overnight (according to the directions from GIBCO BFZL, Gaithersburg, MD). N a H C O 3 alone was added to the control wells. The plates were washed three times with Dulbecco's PBS and 100 btl of 2% BSA was added to each well for 2 h at room temperature to block plates. After another wash with PBS 100 t*I of CD4/CD8-depleted or IgM-depleted appendix cell suspensions in PBS (107/ml) were added and incubated for 1 h at 37~ To isolate C D 4 / C D 8 or IgM-depleted appendix cells, cells were first incubated with biotin-conjugated mouse anti-rabbit CD4 and mouse anti-rabbit CD8 mAbs or biotin-conjugated polyctonal anti-rabbit IgM. After washing with PBS-I% BSA, the cells were incubated with Dynabeads M-280 streptavidin and bound cells were removed using a magnet (MPC; Dynal Inc.). The plates were rinsed very gently three times with PBS and cells fixed with 100 ~1 of formalin solution (10% in PBS) for 3(1 rain at room temperature followed by addition of 50 I~l of toluidine blue (1% [wt:vol] in 10% formalin solution) and incubation for another 30 min. After extensive washing with deionized water, plates were air dried, cells solubilized by addition of 1()0 ~.1 2% SI)S and incubation for 15 rain at 37~ and absorbance was measured at 650 nm using a microtiter plate reader (Molecular Devices Corporation, Menlo Park, CA). The relative absorbance was calculated as a ratio of each sample to the control.
Flow Cytonletry. Total ,appendix cells were first incubated with VHa2 + F(ab')2-biotin then washed with PBS and stained with flunrescein-conjugated goat anti-rabbit IgM and streptavidin-PE conjugate. Cells stained with BSA-biotin and FITC-labeled norreal goat IgG served as a negative control. C D 4 / C D 8 depleted appendix cells (isolated as described above) were incubated with BSA-biotin, mutant Vna2-F(ab')2-biotin, VHa2 + F(ab')2-biotin, or unlabeled anti-CD5 antibody (clone T1) followed by VHa2 + F(ab')2-biotin for 30 rain at 4~ The cells were washed and incubated for 30 mm at 4~ with streptavidin-fluorescem conjugate. For competitive inhibition studies, total appendix cells were incubated with a nonsaturating amount of PE-conjugated anti-CD5 (CD5-PE; clone TI-IKI)I). PE-conjugated mouse lgG2a served as a negative control. I)ifferent concentrations of F(ab')2 or nonconjugated anti-CD5 were incubated with the 1{) p,g anti-CD5-PE for 40 rain at 4~ CD5 Isolations from Appendix Cell Lysates. 5 X 10 a appendix cells were isolated from 2-wk-old Vu-mutant (ali/ali) rabbits with no endogenous VHa2 nmlecules. Isolated cells were biotinylated and cell lysates prepared with a cellular labeling and inmmnopre- cipitation kit using biotin-7-NHS (Boehringer Mannheim, Indianapolis, IN). To remove proteins that may bind nonspecifically to the beads, the lysate was first gently rocked with 100 ILl of uncoupled beads (4 • 10 ~ beads/M) for 30 min at 4~ and complexes removed with a magnet. This step was repeated three times. The lysate was then divided into two equal aliquots. One aliquot was first incubated on a rocking platform at 4~ overnight with 300 btl of Dynabeads M-450 coupled with anti-human CD5 antibody (T1). The complexes were collected with a magnet and supernatants removed carefully. Both aliquots were first precleared with VHa2-F(ab')2-coated Dynabeads M-280 for 5 h at 4~ on a rocking platform and then incubated with VHa2 + F(ab')2-coated beads overnight at 4~ The complexes were collected again with a magnet and supernatants removed. Dynabead complexes were washed twice in buffer 1 (50 mM Tris, 150 mM NaC1, and 0.1% NP-40) then twice in buffer 2 (50 mM Tris, 50 mM NaC1, and 0.1% NP-40) and finally once in 10 mM Tris buffer, pH 7.5. The beads were boiled in SDS gel-loading reducing buffer for 3 min and protein content analyzed by 15% SDS-PAGE Ready Gels (Bio-R.ad Laboratories, Hercules, CA) and a streptavidin-peroxidase chemiluminescence technique according to the manufacturer's instructions.
Results

Biotinylated F(ab ')2 Fragments Stain Dark Zone Cells of Appendix Germinal Center and the Staining Is Inhibited by anti-CD5 Antibody. To identify a ligand for VH FR1 and FR3
of B cell surface immunoglobulin, we purified and biotinylated F(ab')2 fragments from rabbit IgG and used them as well as VH fragments (lacking an associated VL) to assess binding to appendix germinal center cells by immunohistochemistry. Biotin-labeled F(ab')2 or VH fragments mainly stained germinal centers with high intensity in the dark zones and low intensity in the light zones (Fig. 1, a and d) . A similar pattern of staining was observed in appendix follicles stained by either mouse anti-rabbit CD5 mAb tLCD5 (1), or a mouse anti-human CD5 mAb, T1 (22) (Fig. 1 b and data  not shown) . Staining of the germinal centers by biotinlabeled F(ab')2 can be inhibited by prior incubation of tissue sections with anti-CD5 antibodies (Fig. 1 c) , suggesting that F(ab')2 fragments bind to the CD5 molecules on dark zone B cells. Similarly, staining of the germinal centers by anti-CD5 antibody can be inhibited by preincubation of tissue sections with purified V H (Fig. 1 e) . Thus, the interaction of CD5 and VH does not require VL. In addition, some but not all affinity-purified rabbit antibodies stain dark zones of the appendix and the staining can be inhibited by anti-CD5 antibodies (data not shown). Together these data argue that CD5-VH interaction is framework region specific and is not dependent on antibody specificity, although changes in VH sequences can alter or eliminate binding.
VHa2 + F(ab')2 Binds to IgM + Appendix B Cells and the Binding Is Specifically Inhibited by anti-CD5 Antibody. To de-
termine which cell subpopulation binds to F(ab')2, we used a cell attachment assay. IgM-depleted cells, enriched for nonlymphoid cells, did not bind to VHa2 + or VHa2-F(ab')2 coated plates (Fig. 2) . In contrast, CD4/CDS-depleted appendix cells, mainly IgM + B cells, showed binding to F(ab')2 fragments, especially to those bearing VHa2 determinants. By flow cytometry, we confirmed that F(ab')2-biotin stained IgM-positive appendix B cells (Fig. 3 a) . CD4/CDS-depleted appendix B cells stained positively with biotinylated V.a2 + F(ab')2 (solid thick line) but not with mutant VHa2-F(ab')2 (Fig. 3 b, solid thin line) . In addition, anti-CD5 mAb was able to inhibit the interaction between biotinylated F(ab')2 and appendix B cells (dotted line, Fig. 3 b) . This is consistent with the immunohistochemistry data and again indicates that F(ab')2 binds to CD5 on B cells. Under conditions of competitive inhibition, F(ab')2 fragments were unable to inhibit binding of 10 b~g of anti-CD5-PE to CD5 although unlabeled anti-CD5 antibody inhibited the binding (Fig. 3 c) . Thus F(ab')2 has a lower relative avidity compared to the anti-CD5 for the site on CD5 recognized by this mAb.
Immobilized F(ab')2 Fragments Isolate CD5 Molecules from Appendix Cell Lysates. To isolate the molecule on B cells
that interacts with F(ab')2 fragments, we covalently coupled 
closed circles).
The data were expressed as mean fluorescence minus control and percent inhibition calculated relative to CD5-PE in the absence of any inhibitor.
purified F(ab')2 fragments to Dynabeads. Coated beads were then used to isolate F(ab')2 ligand from lysates o f surface biotinylated appendix cells. Similarly, anti-CD5 antibodies (T1 and R C D S ) were coupled to the Dynabeads. Anti-CD5 coated beads isolated two molecules (Fig. 4 and data not shown), one migrating at the position corresponding to its expected relative molecular mass of 67,000 (67,000 Mr) on SDS-PAGE and one of 56,000 (56,000 Mr) most likely representing a differently glycosylated form of CD5 (23) . VHa2 + F(ab')2-coupled beads also isolated two molecules from the cell lysate precleared with VHa2-F(ab')2-coupled beads. These had the same molecular mass as those from anti-CD5 coated beads, the major one of 67,000 (67,000 Mr) and another one of 56,000 (56,000 Mr). The 56,000 molecule was isolated by both anti-CD5 and F(ab')2 coupled beads but not by control uncoupled beads; thus it is unlikely to represent a nonspecifically bound molecule. Furthermore, when cell lysates from biotinylated appendix cells were first preincubated with anti-CD5-coated beads, these two molecules were no longer isolated by VHa2 + F(ab')2 beads. In addition, some affinity-purified rabbit antibodies also isolated CD5 molecules from cell lysates (data not shown) arguing again that C D 5 -V H interaction is framework region specific and is not dependent on antibody specificity. 
Discussion
Interaction of F R structures on B cells with previously unidentified ligand(s) was postulated to contribute to antigenindependent signals to survive rather than undergo apoptosis (18, 24) . The data reported here demonstrate an interaction between CD5 and B cell surface immunoglobulin, most likely involving framework region sequences. W e showed earlier that "positive" selection occurs during B lymphocyte development in the rabbit appendix (18) . This selection favors B cells with receptors bearingVHa2 + structures in the first and third framework regions. VHa2 + structures as F(ab')2 fragments bind IgM + B cells irrespective of antibody specificity and the binding can be inhibited by anti-CD5 antibodies. Thus CD5 is a potential selecting ligand that contributes to survival and expansion of B cells with VHa2 + surface IgM.
Most dark zone B cells in appendix germinal centers express high levels of CD5 (Fig. 1 b) and the majority of B cells in normal animals bear VHa2 framework regions encoded by the VH1 gene (13, 15) . The presence o f both CD5 and VHa2 on the same cell raises the possibility of a relationship between the coexpression of these interacting proteins and the self-renewing capacity of these cells. Future investigations must determine whether the expansion we observed is mediated through signals transmitted by VHa2 stimulating CD5, CD5 stimulating the Vrta2-associated B cell receptor (BCR) or both. Selective expansion of VHa2 + B cells in the appendix could occur via CD5-V, interaction either on the same cell or through interactions with nearby cells in a developing cluster.
A role for CD5 as a candidate selecting ligand is further suggested by its physical and functional coupling to the BCtL (25) . Thus CD5 accessory molecules in the BC1L complex on CD5 + B cells may have a unique potential to modulate BC1L signals after interaction with antigens or superantigens (25, 26) . A limited repertoire of V, genes has been observed in the CD5 + B cell populations of human and mouse (27, 28) . This may also reflect selective B cell expansion during fetal and neonatal B cell development through interactions with autologous antigens or superantigens (10, 29) .
Studies of the phenotype of a CD5 knockout mouse suggest that CD5 may play a role in positive selection of developing thymocytes with specific antigen receptors (30) .
Similarly, the interaction between CD5 as a surface ligand and its receptor on the same or other B cells may generate distinct activation signals at different stages of B cell development and selection. As B lymphocytic leukemia cells express CD5 (31), and CD5 + (BI) B cells provide a source of autoantibody-producing cells (25) (26) (27) , the CD5-framework region interaction might contribute to autostimulatory growth of transformed cells as well as mediate selection of autoreactive repertoires. CD5 may interact directly with a counterreceptor, such as CD72 (32, 33) or VH and transmit modulating signals to the B cell. The amount of signaling and qualitative differences in signaling may determine B cell negative or positive selection (34) . CD5-VH interaction alone may induce a signal that is sufficient to promote expansion and/or survival of B cells or may influence the fate of B cell selection in combination with other signals.
Our data provide evidence for CD5-V, framework region interaction and suggest it may affect maintenance and selective expansion of particular B cells. After V, ligand recognition, CD5 stimulation may also be a promoting factor in the evolution ofautoimmune or transformed cells.
